Controlled adherence with long-acting injectable cabotegravir plus rilpivirine: determinants and clinical impact of injection-schedule adherence in the Spanish RELATIVITY cohort

Luis Buzón-Martín, Noemí Cabello-Clotet, Alejandro de Gea-Grela, Guillermo Cuevas, María José Galindo, Rosa María Martínez, David Rial, María Remedios Alemán, Miguel Torralba, Francisco Fanjul, María Carmen Fariñas, Adrián Rodriguez, María José Crusells, Sonia Calzado, Javier Pérez Serrano, Carmen Hidalgo-Tenorio, Luis Enrique Morano, David Vinuesa, Enrique Bernal-Morel, Inmaculada Poquet-Catalá, Hadrián Pernas-Pardavila, Juan Tiraboschi, Diana Corps, María Jesús Vivancos, Jesús Troya

Open source

DOI
10.1097/qad.0000000000004629
Published
2026-10-23
Container
AIDS
Publisher
Ovid Technologies (Wolters Kluwer Health)
Open access
unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1097/qad.0000000000004629,
  title = {Controlled adherence with long-acting injectable cabotegravir plus rilpivirine: determinants and clinical impact of injection-schedule adherence in the Spanish RELATIVITY cohort},
  author = {Luis Buzón-Martín and Noemí Cabello-Clotet and Alejandro de Gea-Grela and Guillermo Cuevas and María José Galindo and Rosa María Martínez and David Rial and María Remedios Alemán and Miguel Torralba and Francisco Fanjul and María Carmen Fariñas and Adrián Rodriguez and María José Crusells and Sonia Calzado and Javier Pérez Serrano and Carmen Hidalgo-Tenorio and Luis Enrique Morano and David Vinuesa and Enrique Bernal-Morel and Inmaculada Poquet-Catalá and Hadrián Pernas-Pardavila and Juan Tiraboschi and Diana Corps and María Jesús Vivancos and Jesús Troya},
  year = {2026},
  journal = {AIDS},
  doi = {10.1097/qad.0000000000004629},
  url = {https://doi.org/10.1097/qad.0000000000004629}
}

RIS

TY  - JOUR
TI  - Controlled adherence with long-acting injectable cabotegravir plus rilpivirine: determinants and clinical impact of injection-schedule adherence in the Spanish RELATIVITY cohort
AU  - Luis Buzón-Martín
AU  - Noemí Cabello-Clotet
AU  - Alejandro de Gea-Grela
AU  - Guillermo Cuevas
AU  - María José Galindo
AU  - Rosa María Martínez
AU  - David Rial
AU  - María Remedios Alemán
AU  - Miguel Torralba
AU  - Francisco Fanjul
AU  - María Carmen Fariñas
AU  - Adrián Rodriguez
AU  - María José Crusells
AU  - Sonia Calzado
AU  - Javier Pérez Serrano
AU  - Carmen Hidalgo-Tenorio
AU  - Luis Enrique Morano
AU  - David Vinuesa
AU  - Enrique Bernal-Morel
AU  - Inmaculada Poquet-Catalá
AU  - Hadrián Pernas-Pardavila
AU  - Juan Tiraboschi
AU  - Diana Corps
AU  - María Jesús Vivancos
AU  - Jesús Troya
PY  - 2026
JO  - AIDS
DO  - 10.1097/qad.0000000000004629
UR  - https://doi.org/10.1097/qad.0000000000004629
ER  - 

APA

Buzón-Martín, L., Cabello-Clotet, N., Gea-Grela, A. D., Cuevas, G., Galindo, M. J., Martínez, R. M., Rial, D., Alemán, M. R., Torralba, M., Fanjul, F., Fariñas, M. C., Rodriguez, A., Crusells, M. J., Calzado, S., Serrano, J. P., Hidalgo-Tenorio, C., Morano, L. E., Vinuesa, D., Bernal-Morel, E., Poquet-Catalá, I., Pernas-Pardavila, H., Tiraboschi, J., Corps, D., Vivancos, M. J., & Troya, J. (2026). Controlled adherence with long-acting injectable cabotegravir plus rilpivirine: determinants and clinical impact of injection-schedule adherence in the Spanish RELATIVITY cohort. AIDS. https://doi.org/10.1097/qad.0000000000004629

Source records